Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Bryce

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
The Oncologist|April 8, 2009
Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directionsAlessandro Morabito, Maria Carmela Piccirillo, Fabiano Falasconi, et al.
Frontiers in Bioscience (Elite Edition)|December 29, 2009
"CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression"Renato Franco, Gerardo Botti, Massimo Mascolo, et al.
Cancer Immunology, Immunotherapy : CII|March 9, 2012
Inhibition of stromal CXCR4 impairs development of lung metastasesCrescenzo D'Alterio, Antonio Barbieri, Luigi Portella, et al.
Cytokine|March 7, 2006
Soluble interleukin-2 receptor in stage I-III melanomaAlessandro Ottaiano, Enrico Leonardi, Ester Simeone, et al.
Expert Review of Anticancer Therapy|February 10, 2012
Cetuximab in non-small-cell lung cancerGuido Carillio, Agnese Montanino, Raffaele Costanzo, et al.
Expert Review of Anticancer Therapy|February 24, 2011
Anticancer effect of bisphosphonates: new insights from clinical trials and preclinical evidenceGennaro Daniele, Pasqualina Giordano, Antonella De Luca, et al.
Journal of Biomedicine & Biotechnology|June 11, 2011
Gefitinib in non small cell lung cancerRaffaele Costanzo, Maria Carmela Piccirillo, Claudia Sandomenico, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2005
Prospective clinical trials of biotherapies in solid tumors: a 5-year surveyAlessandro Ottaiano, Ernesto Mollo, Giuseppe Di Lorenzo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervixKosei Hasegawa, Shoji Nagao, Masanori Yasuda, et al.
BMJ Open|September 11, 2019
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocolSilvia Riva, Jane Bryce, Francesco De Lorenzo, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
The Oncologist|April 8, 2009
Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directionsAlessandro Morabito, Maria Carmela Piccirillo, Fabiano Falasconi, et al.
Frontiers in Bioscience (Elite Edition)|December 29, 2009
"CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression"Renato Franco, Gerardo Botti, Massimo Mascolo, et al.
Cancer Immunology, Immunotherapy : CII|March 9, 2012
Inhibition of stromal CXCR4 impairs development of lung metastasesCrescenzo D'Alterio, Antonio Barbieri, Luigi Portella, et al.
Cytokine|March 7, 2006
Soluble interleukin-2 receptor in stage I-III melanomaAlessandro Ottaiano, Enrico Leonardi, Ester Simeone, et al.
Expert Review of Anticancer Therapy|February 10, 2012
Cetuximab in non-small-cell lung cancerGuido Carillio, Agnese Montanino, Raffaele Costanzo, et al.
Expert Review of Anticancer Therapy|February 24, 2011
Anticancer effect of bisphosphonates: new insights from clinical trials and preclinical evidenceGennaro Daniele, Pasqualina Giordano, Antonella De Luca, et al.
Journal of Biomedicine & Biotechnology|June 11, 2011
Gefitinib in non small cell lung cancerRaffaele Costanzo, Maria Carmela Piccirillo, Claudia Sandomenico, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2005
Prospective clinical trials of biotherapies in solid tumors: a 5-year surveyAlessandro Ottaiano, Ernesto Mollo, Giuseppe Di Lorenzo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervixKosei Hasegawa, Shoji Nagao, Masanori Yasuda, et al.
BMJ Open|September 11, 2019
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocolSilvia Riva, Jane Bryce, Francesco De Lorenzo, et al.
Pageof 4